Top DoubleJump Interchange Alternatives

Cleerly is an innovative digital health company that is transforming the approach healthcare professionals take in addressing heart disease. Our cutting-edge clinical technologies empower clinicians to identify and accurately define atherosclerosis at its inception, facilitating the creation of personalized and potentially life-saving treatment options for patients throughout their healthcare experience. Instead of depending on indirect signs such as risk factors or symptoms, we prioritize direct measurements of atherosclerosis, which reflects the buildup of plaque in the heart's arteries. By harnessing our AI-powered digital care pathways, we deliver efficient, quick, and precise diagnostics and reporting that meet the needs of all parties involved, resulting in improved clinical outcomes and financial performance. Cleerly allows healthcare practitioners to go beyond traditional evaluations of heart disease by comprehensively analyzing, characterizing, and quantifying different types of plaque. This forward-thinking strategy not only aids clinicians in evaluating a patient's risk of a heart attack but also supports the development of effective treatment plans aimed at enhancing overall heart health. As a result, we contribute to better patient outcomes and elevate the quality of care provided in the healthcare system. By redefining the standards of heart disease management, Cleerly is setting a new benchmark for patient-focused healthcare.

DARA is at the forefront of transforming clinical decision-making and intervention techniques through a foundation built on proven medical science and clear systems biology. By partnering with healthcare professionals and key stakeholders, we provide innovative digital solutions that significantly improve health screening processes and the management of chronic conditions. Our strategy promotes the digital advancement of healthcare delivery by automating clinical workflows and integrating predictive analytics, ensuring alignment with the highest clinical guidelines and best practices available. We empower physicians with valuable health insights derived from customized predictions regarding disease risks and possible adverse outcomes, enhancing their ability to engage with patients effectively. Furthermore, we contribute to the pharmaceutical sector by revealing pharmacodynamics within complex biological systems and identifying novel therapeutic pathways. The use of predictive analytics applied to extensive patient data enhances personalized precision medicine, particularly in the realm of cardiometabolic diseases, helping to prevent severe health crises. With our advanced tools, healthcare can transition to a more proactive and adaptable model, fostering significantly improved patient care and overall health results. As we continue to innovate, our commitment to advancing the quality of care remains unwavering, paving the way for future developments in health technology.

Boost your clinical research revenue by addressing gaps in patient care. CliniWorks’ AccelInsight™ Analytics Application supports Population Health Management by equipping clinical decision-makers with detailed reports and tools aimed at identifying areas of inadequacy in patient treatment across multiple disease categories. This application provides customized, near-real-time analytics sourced from an extensive range of structured and unstructured data, including patient medical histories, to reveal chances for quality improvement, risk stratification, and gap analysis in care management. Furthermore, AccelCare™ empowers healthcare professionals to effectively deploy preferred intervention strategies grounded in best-practice guidelines. It also aligns patient cases from medical records with established medical protocols and workflows, triggering corrective processes and real-time alerts to quality assurance teams, management, and healthcare providers to enhance the patient care continuum. Ultimately, this comprehensive strategy not only promotes clinical excellence but also cultivates a culture of ongoing enhancement within healthcare organizations, ensuring they remain at the forefront of patient care innovation.

Atropos Health provides instant access to real-world data, effectively bridging the divides in healthcare and life sciences. Proven to improve clinical outcomes, speed up research initiatives, and boost operational efficiency, Atropos Health transforms medical data into actionable insights, compressing research timelines from months to just minutes. At the core of our services is a generative evidence acceleration operating system that facilitates the secure organization and installation of medical information for future use. Our advanced analytics capabilities allow for on-demand evidence generation and can easily integrate with your existing data systems after installation, or take advantage of our expansive global evidence network, which includes over 160 million patient records and a repository of 10,000 prior studies. By partnering with Atropos Health, prominent health systems and life science organizations can accelerate research, improve clinical trials, enhance decision-making in clinical settings, address discrepancies in care, and much more, ultimately reshaping the landscape of healthcare innovation. Join us in transforming the approach to harnessing evidence in medicine, fostering a future where data drives improved patient outcomes and healthcare practices.

Aiforia empowers both pathologists and researchers operating in preclinical and clinical lab environments by offering sophisticated deep learning and cloud-based solutions intended to optimize image analysis and improve operational workflows. By enabling researchers to uncover new disease biomarkers, helping R&D scientists to shorten the timelines for the creation of innovative therapies, and assisting pathologists in enhancing accuracy in cancer diagnoses, Aiforia utilizes its deep expertise to transform healthcare from the discovery stage all the way to diagnosis. For clinical pathology labs aiming to increase their productivity and improve diagnostic precision, Aiforia Clinical Suites provide a versatile suite of AI-driven diagnostic tools, advanced visualization capabilities, robust quality control protocols, and automated processes for pre- and post-screening. Moreover, we are currently developing tailored Suites specifically for some of the most prevalent cancers globally and have successfully obtained CE-IVD certification for our AI models targeting lung and breast cancer. As we continue to advance our technology, we remain committed to significantly enhancing patient outcomes while simultaneously optimizing laboratory operations. The potential impact of our innovations extends beyond immediate diagnostics, paving the way for a future of more personalized and effective healthcare solutions.

Elevate your risk management capabilities and enhance the quality of care for your community by utilizing the disease prediction models available in CARE™. Our platform offers an extensive overview of medical claims data on a national level, which can be customized to address the precise requirements of our clients in detail. By analyzing billions of medical claims, our advanced models identify critical risk factors associated with early disease onset or the need for surgical procedures. With access to this essential information, healthcare professionals can begin diagnoses and treatments sooner, potentially saving lives in the process. Although our prediction models are developed using a vast array of national data, they are equally adaptable to your own electronic health records, population health systems, or member claims databases, allowing for a more tailored approach. Moreover, our physician matching functionality connects patients with the most appropriate healthcare providers, improving their treatment journey toward the best possible outcomes. Utilizing clinically relevant data, our state-of-the-art disease prediction models can detect individuals at risk of developing various conditions, empowering you to reach out and start treatment before issues worsen. This proactive approach not only leads to better patient outcomes but also streamlines the overall healthcare delivery process, ultimately benefiting the entire community. By embracing these tools, healthcare organizations can transform their approach to patient care and risk management.

At Clinipace, we offer a distinctive level of teamwork and oversight that significantly surpasses the standards found in traditional contract research organizations. Our goal is to adeptly navigate you through the intricate processes of your clinical development initiatives. As a comprehensive global CRO, we emphasize a tailored approach to clinical research. We focus on adaptability and cooperation, bolstered by our extensive regulatory knowledge and expertise across a variety of therapeutic fields. Our aim is to revolutionize the clinical research landscape in areas such as oncology, rare diseases, gastroenterology, nephrology, and women's health. By harnessing state-of-the-art technology and a flexible approach, Clinipace is committed to influencing the future of drug development and improving health care results. Our dedication to pioneering solutions allows us to stay ahead in industry advancements, ultimately benefiting the patients we serve. In this rapidly evolving environment, we strive to maintain our leadership position while fostering innovation at every step.

We explore health beyond conventional medical settings to better understand the impact of diseases on individuals. This comprehensive view of patient health uncovers new opportunities for business by introducing innovative ways to measure disease and overall wellness. By focusing on how illnesses influence everyday life, we can improve engagement with both healthcare providers and insurance payers, while also enhancing support for patients. Our goal is to create advanced algorithms that can predict the onset and progression of diseases, as well as identify key moments for timely interventions. Leveraging real digital data, we promote the benefits of our services. Our technology-enabled platform supports real-world research that incorporates unique behavioral data from daily life, offering advantages to clinical, medical affairs, and commercial sectors through Evidation's virtual research hub, Achievement. With customizable study designs and strategies for device integration, we streamline protocol management to ensure effective study execution. Moreover, we provide the option for sponsorship by either our team or your organization, fostering collaborative efforts tailored to specific needs. Ultimately, this approach aims to enhance the overall healthcare landscape by integrating innovative methodologies that benefit all involved stakeholders.

At Genospace, we understand that while progress in genomics is driving the advancement of precision medicine, the task of effectively scaling its implementation remains a significant hurdle. Our objective is to close this gap by leveraging our innovative platform, which is designed to convert biomedical data into actionable insights that are readily available to all, especially those involved in patient care. By empowering clinicians and researchers with crucial information, we enable them to make informed decisions while working toward our shared vision of using complex molecular data to improve patient outcomes and accelerate drug development and research processes. The importance of extensive population data for drug discovery and research is paramount in this endeavor. Take advantage of cohort-driven analyses through the Genospace platform to bolster your research projects. With a dedicated focus on clinical trial research, our platform effectively connects disparate patient data with intricate trial requirements, ensuring faster patient recruitment. Additionally, we aim to seamlessly weave genomic medicine into routine clinical practices, thus simplifying the integration of genomic insights into everyday healthcare. By collaborating closely, we can redefine the limits of patient care and research, ultimately fostering a more informed healthcare ecosystem.

Accelerating the development of essential drugs while guaranteeing equitable access to high-quality cancer therapies and research for patients globally is paramount. Our innovative technology is revolutionizing patient access to state-of-the-art medications and participation in clinical trials. FICS represents a pioneering software solution that streamlines the collection of regulatory-compliant data during patient treatment. By unifying disparate and previously disconnected applications into a cohesive and efficient platform, FICS enhances the speed and quality of clinical trials, which significantly improves patient outcomes. This transformative approach not only simplifies the trial process but also fosters better collaboration among researchers and healthcare providers.

As companies expand their onsite clinic offerings to include primary care, urgent care, chronic disease management, and wellness programs, a typical occupational health IT system falls short of meeting these increased demands. Enterprise Health addresses this gap by merging occupational health, compliance, clinical care, and employee engagement into one cohesive ONC-ACB certified EHR, delivering a robust solution that caters to both occupational health and corporate wellness goals. This platform streamlines the tracking and management of health surveillance, work-related illnesses and injuries, along with clinical services, while also motivating employees to actively participate in their health and wellness journeys. With the diverse toolsets provided by Enterprise Health, employees can engage in direct communication with clinical staff and easily access important health information, empowering them to improve their well-being and that of their families. Moreover, this integration cultivates a wellness-oriented culture within the workplace, ultimately enhancing employee morale and productivity. Consequently, organizations that adopt such comprehensive systems are likely to see a significant return on investment in terms of health outcomes and employee engagement levels.

Oncoustics is at the forefront of creating and implementing groundbreaking, patented AI technologies designed to deliver affordable, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently present substantial clinical difficulties. The firm has introduced a suite of specialized applications aimed at different diseases and anatomical structures, which seamlessly integrate with any point-of-care ultrasound device, enabling healthcare providers, including physicians, nurses, and technicians, to use them as vital tools in primary care settings without the necessity for image analysis. By harnessing the power of AI, Oncoustics converts economical point-of-care ultrasound machines into advanced diagnostic tools that facilitate swift and cost-effective identification and monitoring of conditions related to the liver, prostate, kidney, breast, and thyroid. The diverse team behind Oncoustics comprises experts in AI, signal processing, radiology, hepatology, digital health, and ultrasound, fostering a holistic approach to healthcare advancement. Their focus on affordable point-of-care diagnostics and surveillance greatly improves patient outcomes through timely detection and consistent oversight, which are essential for effective disease management and enhanced overall health. Furthermore, Oncoustics is not merely tackling existing healthcare challenges but is also paving the way for a revolutionary shift in future disease management strategies, ensuring that the healthcare landscape evolves to meet the needs of patients more effectively. This forward-thinking approach positions Oncoustics as a key player in reshaping the future of medical diagnostics and patient care.

Our versatile and comprehensive array of solutions is designed within a strategic framework that empowers organizations to analyze and predict trends within communities, engage individuals along with their families and care teams in proactive initiatives, and enhance health management for better overall well-being. In contrast to traditional healthcare, which often focuses solely on the individual and associates "health" with merely the absence of illness, population health management expands this perspective by implementing strategies that benefit entire communities while emphasizing the importance of preventing and managing chronic diseases. To effectively manage population health outcomes, it is essential to tackle the root causes of health challenges, enabling healthcare providers to anticipate, prevent, and mitigate issues before they occur. By merging clinical data with social determinants of health (SDoH), healthcare professionals can uncover critical insights that not only elevate individual care but also pave the way for collaborative efforts with communities to enhance overall health and wellness. This holistic strategy ultimately aspires to cultivate healthier populations, and more efficient healthcare systems, while fostering a culture of preventive care and community engagement.

DoseMeRx is recognized as the world’s first and largest Bayesian dosing platform, specifically designed for clinical applications. Our advanced platform expedites your path to achieving clinical goals while significantly improving patient outcomes and minimizing costs. Distinctively, we are the only Bayesian dosing solution in the world that possesses HITRUST certification, ensuring that patient data is safeguarded with the highest standards of protection and integrity. Benefit from uninterrupted continuity of care across your healthcare system through a few straightforward steps. You can effortlessly standardize your workflows and optimize your therapeutic drug monitoring strategies. Our extensive range of drug models covers various therapeutic areas, including vancomycin and infectious diseases, transplant medicine, cardiovascular and coagulation care, as well as oncology and pediatrics, providing comprehensive support for numerous clinical situations. This adaptability not only enhances the quality of care but also enables healthcare professionals to offer personalized treatment options with greater efficiency. Ultimately, DoseMeRx empowers providers to meet the unique needs of their patients, fostering improved health outcomes across diverse populations.

HolCare EHR+ is a sophisticated electronic health record system hosted in the cloud, specifically designed to meet the needs of mental health organizations, telepsychiatry services, research centers, and forward-thinking care models. By implementing Measurement-Based Care (MBC), it has been shown to significantly enhance patient care, improve treatment outcomes, and aid clinicians in making informed decisions, which collectively yield better health results. However, the challenge of integrating MBC directly with an EHR can complicate its application and may reduce overall efficiency. HolCare EHR+ resolves this complication by offering comprehensive MBC integration, which allows for the smooth gathering of critical measures that improve patient care. Moreover, its native support for HL7 FHIR enables easy integration with a wide range of third-party health technologies. This standardized approach prevents the challenges associated with expensive and lengthy custom integrations, resulting in a more effective platform capable of exchanging both clinical and non-clinical data with partners, thus optimizing workflows within the healthcare landscape. In doing so, HolCare EHR+ not only promotes a more cohesive method for managing patient care but also encourages organizations to embrace innovative strategies in health service delivery. Ultimately, this positions HolCare EHR+ as a key player in transforming the way healthcare is approached and administered.

Improving the quality of care and outcomes for cancer patients requires an integrated approach that involves healthcare providers, researchers, cancer organizations, and the patients themselves. Oncora's user-friendly software platform equips all stakeholders with the ability to collect and analyze real-world data, enabling healthcare decisions that focus on the well-being of patients. Our solutions cater specifically to healthcare professionals dedicated to enhancing cancer treatment outcomes. By streamlining workflows, easing documentation burdens, and refining care with intelligent software solutions, we strive to create a more effective healthcare experience. Our user-friendly tools facilitate the capture and visualization of regulatory-grade real-world data, which is crucial for making informed decisions. With advanced reporting features, you can assess quality and improve operations to enhance patient care significantly. Partnering in comprehensive clinical research with top cancer care specialists further solidifies our dedication to improving the field. The web-based software we provide is customized to satisfy the unique requirements of your cancer center, offering data and resources that accelerate clinical advancements and innovations. Ultimately, our goal is to revolutionize cancer care through the synergy of technology and collaboration, ensuring patients benefit from the best possible care available. By fostering these connections, we can drive meaningful change in the fight against cancer.

Jvion goes beyond traditional predictive analytics by revealing hidden patient risks tied to various health conditions and clinical situations, while also exploring how these risk patterns can be redirected to achieve better outcomes. Through the use of our prescriptive AI, we provide personalized recommendations for patients by analyzing an extensive range of elements, including clinical, socioeconomic, and behavioral data alongside established best practices. This valuable insight equips healthcare organizations to improve quality, decrease costs, and enhance the overall experience for patients. We examine a diverse set of clinical, socioeconomic, environmental, and behavioral information to identify unnoticed health and financial vulnerabilities. By focusing on modifiable patient traits, we craft targeted action plans tailored to each individual. Our methodology offers evidence-driven, prioritized, and patient-specific guidelines that integrate smoothly into existing workflows. In response to the ongoing pandemic, the importance of home care has been revitalized, as numerous patients now opt for at-home treatment to lower their risk of exposure to Covid-19 and other health threats. This significant shift highlights the urgent need for innovative healthcare solutions that address the changing requirements of patients in a post-pandemic era, ultimately fostering a more adaptable healthcare ecosystem.

Specialty and rare diseases frequently involve patient groups that are ambiguously defined, including those who are undiagnosed or improperly diagnosed, as well as healthcare professionals who might be uninformed about these disorders and their diverse presentations, leading to treatment pathways that lack clarity. IPM.ai functions as an Insights-as-a-Service (IaaS) organization, committed to equipping prominent life sciences companies with profound insights into patient care, thereby improving the quality of life for affected individuals via the advancement, clinical investigation, and marketing of therapeutic options. By forecasting market dimensions, scrutinizing the competitive environment, and assessing potential returns on investment, businesses can refine their commercialization tactics effectively. In addition, the platform plays a crucial role in recognizing undiagnosed or misdiagnosed patients who could gain from early intervention and therapeutic solutions. It utilizes statistical methodologies to evaluate the occurrence of particular diseases among specific patient demographics at any time. Moreover, IPM.ai aids in identifying physicians who excel in diagnosing and treating these optimal patients, while also motivating other healthcare practitioners to improve overall patient outcomes. This all-encompassing strategy ultimately seeks to close the gap in understanding and addressing the requirements of individuals with rare diseases, ensuring they receive the attention and care they deserve. By fostering collaboration among healthcare providers, IPM.ai aims to create a more informed and responsive healthcare ecosystem.

Pharmaceutical firms need a wealth of genomic information to successfully execute precision medicine strategies; however, they often utilize only a fraction—around 10%—of the total data at their disposal for decision-making. Genomenon offers an extensive database to counter this limitation. Their Prodigy™ Patient Landscapes deliver a cost-effective and efficient approach for conducting natural history research, which is crucial for developing treatments for rare conditions by expanding the understanding of both past and future health data. Employing a sophisticated AI-driven process, Genomenon meticulously analyzes each patient referenced in the medical literature much faster than traditional methods. It is essential to capture all pertinent insights by examining every genomic biomarker highlighted in scholarly articles. Each scientific assertion is backed by solid evidence sourced from medical literature, enabling researchers to identify all genetic factors and pinpoint variants classified as pathogenic according to ACMG clinical criteria, thus streamlining the creation of targeted therapies. By adopting this thorough strategy, pharmaceutical companies can significantly boost their research efficiency and, in turn, enhance patient outcomes. This innovative model not only fosters advancements in drug development but also contributes to a deeper understanding of genetic influences on health.

Savana is an advanced clinical intelligence platform that employs artificial intelligence to transform unstructured text from electronic medical records into meaningful real-world evidence through advanced natural language processing methods. Since its inception in 2014, Savana has successfully structured and analyzed billions of clinical documents across diverse languages and regions, uncovering insights that were previously hidden within healthcare data. Its EHRead NLP models power tools for both anonymization and pseudonymization, efficiently managing extensive amounts of structured and unstructured data, having processed in excess of 35 million documents to this point. By delivering actionable, research-quality evidence to hospitals, researchers, and health systems, Savana bolsters precision medicine projects, undertakes epidemiological studies—including predictive analyses linked to COVID-19—and enhances overall clinical data strategies, thereby cementing its status as a leading contributor to Health Economics and Outcomes Research (HEOR) in Europe. Furthermore, Savana's cutting-edge approach not only transforms data analysis within healthcare but also fosters improved decision-making processes, which can significantly lead to better patient outcomes and a more effective healthcare system. Through continued innovation, Savana is setting new standards for clinical data utilization and insight generation.

Cyberhealth365 presents a specialized clinical management system designed for efficient electronic record-keeping and practice administration. This cutting-edge solution is intended to supplant traditional paper records by optimizing the handling of patient information and workflows within a healthcare facility, such as a doctor's office or clinic. It systematically organizes appointments for both clinics and polyclinics, guaranteeing that every appointment is confirmed and that patients are reminded through timely email or SMS notifications. By reducing the time dedicated to scheduling, this module not only boosts resource utilization but also effectively mitigates scheduling conflicts, which ultimately leads to reduced costs for the facility. Furthermore, Cyberhealth365 incorporates a national registry system that aggregates extensive data on patients diagnosed with particular diseases, offering healthcare providers and researchers crucial insights into similar health conditions, thus enhancing the understanding of these medical issues. This comprehensive approach not only elevates operational efficiency but also plays a significant role in the progression of medical research and the quality of patient care. Additionally, by leveraging technology, healthcare professionals can make informed decisions that improve overall patient outcomes.

Tellihealth has introduced a cutting-edge Remote Patient Monitoring (RPM) solution called accuRPM, which is a cloud-based system that allows healthcare professionals to monitor patients' health outside traditional medical settings. This platform seamlessly incorporates real-time physiological information from FDA-approved, 4G cellular-enabled medical devices along with actionable clinical insights and AI-driven analytics, ensuring compatibility with current electronic health record systems. By utilizing devices that are easy to install, it circumvents the need for complicated Wi-Fi configurations, automatically transmitting essential health metrics, such as blood pressure, glucose levels, weight, respiratory rate, and oxygen saturation directly to care teams. This capability promotes timely interventions, improves the management of chronic diseases, and contributes to a reduction in hospital admissions. Additionally, Tellihealth’s RPM platform features flexible patient enrollment methods, supports automatic data integration into clinical processes, and includes alert systems along with escalation protocols. It also offers patient engagement tools like mobile app tracking and reminders, ultimately leading to an enhancement in the overall quality of patient care and experience. As a result, healthcare providers can be more proactive in addressing patient needs, further optimizing health outcomes.

DigiLife stands out as a frontrunner in the domain of HIPAA-compliant connected healthcare and telehealth solutions, facilitating remote patient monitoring and assisted treatment. The platform known as Prodoc, or DigiCare Live, is intricately designed on our exclusive technology framework. It provides essential features such as electronic health record (EHR) management, practice administration, chronic condition monitoring through health devices, remote diagnosis via telemedicine, and care coordination with the help of assisted caregivers. This versatile tool is suitable for use by specialists, physicians, and healthcare institutions operating multiple clinics. Furthermore, it seamlessly integrates with many widely-used electronic medical records (EMRs) by adhering to FHIR standards for the exchange of clinical information. Through its capabilities, it significantly enhances health management by offering personalized reminders and intelligent alerts to patients regarding laboratory tests, medications, or telemedicine appointments. Additionally, it supports a variety of popular health and fitness devices, including Fitbit, Google Fit, Withings, and iHealth. You can also customize your service by selecting bespoke development options to meet specific needs. This flexibility ensures that healthcare providers can optimize their use of technology to improve patient care effectively.

SeqOne is a cutting-edge genomic analysis platform that utilizes artificial intelligence to empower molecular laboratories, clinical teams, biologists, and geneticists in transforming complex next-generation sequencing data into swift, precise, and actionable clinical insights that support personalized medicine diagnostics. The platform optimizes the entire genomic workflow—ranging from managing raw sequencing data to variant interpretation and reporting—by automating repetitive tasks, seamlessly integrating with laboratory systems, and leveraging advanced AI models like DiagAI to evaluate and prioritize disease-related variants, ultimately reducing manual effort and expediting turnaround times. SeqOne's adaptability allows it to serve both germline and somatic analyses across a variety of domains, including oncology, rare inherited conditions, and infectious disease detection, while it combines top-tier annotation databases with standardized interpretation protocols to guarantee clinical-grade accuracy. Additionally, it boasts a user-friendly interface that can scale securely via the cloud, making it both accessible and efficient in various clinical settings. The platform not only enhances diagnostic processes but also paves the way for future innovations in genomic analysis technology, thereby significantly advancing the capabilities available within personalized medicine. As such, SeqOne stands as a pivotal resource that can potentially revolutionize how genomic data is utilized in clinical practice.

In the past, clinical trials and medical research were typically conducted in isolation from the everyday care provided by local healthcare providers and individual practitioners. As a result, many doctors were often unaware of the research efforts underway, leaving their patients in the dark about potential studies that could improve their health outcomes. Elligo has revolutionized this scenario by enabling greater involvement in clinical research through access to an extensive network of over 150 million patients and their detailed data, which allows physicians to introduce research opportunities to patients who might not have otherwise been aware of them. The conventional participant recruitment methods frequently encounter obstacles, including the necessity for patients to travel to designated research locations, which can hinder participation rates. Furthermore, research suggests that patients are more likely to engage in studies when these initiatives are associated with their familiar healthcare providers, highlighting the critical need for the integration of clinical research within established medical settings. By adopting this innovative approach, not only do we bridge the divide between research and patient care, but we also empower individuals to actively engage in meaningful medical advancements that could potentially change their lives. This integration fosters a collaborative environment where patients feel more supported and informed about their treatment options.

Flatiron Health's Evidence Solutions offer a flexible approach to producing real-world evidence, whether in a prospective or retrospective manner, assisting life sciences companies in effectively achieving their oncology research goals. Central to this suite of services is Flatiron Horizon, an integrated platform that harnesses a vast collection of over 5 million anonymized patient records alongside 1.5 billion data points, enhanced by sophisticated curation strategies and specialized machine learning models tailored for specific diseases. This groundbreaking platform is crafted to support multiple stages of the biopharma lifecycle, from initial discovery and clinical study design to regulatory submissions and post-marketing obligations. Moreover, Flatiron's offerings provide personalized real-world data configurations that are specifically designed for oncology, allowing for prospective evidence generation via minimally invasive studies while refining protocols to improve patient identification. The platform also guarantees a smooth transition of data from electronic health records to electronic data capture systems through the capabilities of Flatiron Clinical Pipe, which enhances both research efficiency and effectiveness. Consequently, such advanced functionalities not only elevate Flatiron Health's standing as a frontrunner in the oncology research landscape but also significantly contribute to the utilization of real-world data in improving patient outcomes. By continuously innovating, Flatiron Health remains committed to advancing the field of oncology through data-driven insights.

Elevate the well-being and management of your patients using EpicCare, which provides tailored screens, workflows, and specialty applications that are both rapid and versatile. By leveraging predictive analytics and seamless decision support tools, clinical practices can secure enhanced patient outcomes. Routine processes are streamlined for optimal efficiency, resulting in quicker task completion. The availability of mobile applications allows you to stay connected regardless of your whereabouts. Moreover, you can hasten the recruitment of study participants, conduct independent research, and seamlessly incorporate your findings into everyday clinical practice. Healthcare professionals have identified it as the leading acute and ambulatory EMR for boosting physician productivity and effectiveness. The system features adaptable, pre-built content designed for multiple specialties, allowing you to focus more on delivering patient care. Additionally, specialty steering boards, made up of industry experts, play an active role in contributing relevant content and steering development to meet the authentic needs of different specialties, thereby ensuring that the system is in sync with practical clinical demands. This dedication to ongoing enhancement positions EpicCare as an indispensable resource for healthcare practitioners, reinforcing its reputation as a cutting-edge tool in the medical field. Ultimately, EpicCare not only prioritizes patient care but also fosters a culture of innovation in healthcare delivery.

Thorough recommendations are integrated throughout the entire continuum of patient care, guaranteeing that each stage is effectively managed. There is a compelling initiative that promotes the assessment and oversight of both clinical and commercial results. Specific risk algorithms tailored to various diseases, including diabetes, cardiovascular conditions, kidney function, and liver health, have been developed across multiple therapeutic domains. A Comprehensive Wellness Score is implemented to assess the potential need for hospital admission. In addition, proprietary data and standardized protocols are enriched with accessible clinical content designed for patients, which is not only readily available but also adaptable for different uses and formats. Advanced decision support mechanisms utilize both established guidelines and machine learning techniques to scrutinize prescribers' medication prescribing habits. Moreover, a state-of-the-art customer feedback platform has been specifically crafted for healthcare providers, operating on a multi-faceted engine that takes into account various elements like spending, adherence to schedules, preventive healthcare visits, enhancements in clinical metrics and outcomes, along with demographic data, thereby delivering a comprehensive perspective on patient care and intervention requirements. This multifaceted strategy ultimately aims to improve patient outcomes while optimizing the efficiency of the healthcare system. By prioritizing both clinical effectiveness and user engagement, the approach strives for a more informed and responsive healthcare experience.

Altris AI represents a groundbreaking clinical decision support system that utilizes artificial intelligence and operates in the cloud to assist eye care experts in interpreting OCT scans and enhancing their clinical decision-making processes. This innovative platform facilitates the swift identification of pathological OCT scans while demonstrating the capability to recognize more than 70 different retinal pathologies and biomarkers, including some that are relatively rare. Key features include assessing the severity of conditions, analyzing retinal layer thickness, segmenting various layers, detecting pathologies, and executing both automatic and manual measurements. Altris AI is designed to work seamlessly with all OCT devices and supports multiple formats like DICOM, JPEG, and PNG. The system has received FDA clearance and CE certification and complies with GDPR and HIPAA regulations, thus ensuring the highest standards of data security and patient confidentiality. By integrating Altris AI into their clinical workflows, eye care professionals can significantly enhance patient triage, boost diagnostic accuracy, and monitor disease progression more effectively, which contributes to improved patient outcomes. Furthermore, this state-of-the-art technology not only empowers eye care providers to make better-informed decisions but also promotes an overall atmosphere of enhanced patient care and innovative treatment approaches. Ultimately, the adoption of Altris AI can transform the landscape of eye care, leading to advancements in both patient management and clinical practices.

Our groundbreaking method is designed to be user-friendly for practitioners at all experience levels, enabling straightforward wound evaluation through smartphone photography, which allows clinicians to assess wound conditions and create necessary documentation for reimbursement. By optimizing wound care management, healthcare professionals can improve their star ratings and decrease patient readmission rates, turning successful wound care outcomes into valuable marketing tools that attract more patients. This development gives providers the confidence to take on more complex wound cases with ease. At Swift, we firmly believe that the future of healthcare will be driven by innovative technologies that are carefully crafted to elevate clinical care standards. As smartphone cameras continue to reach their full potential in medical settings, the healthcare industry stands on the brink of remarkable advancements with the advent of new technologies—both in medical facilities and home settings—that encourage a reimagining of care delivery. Consequently, Swift has engineered the world's most advanced smartphone imaging platform, capable of producing research-quality clinical images in any location where patients may be, guaranteeing that high-quality care remains accessible at all times. This cutting-edge solution not only simplifies the wound assessment process but also significantly improves patient outcomes across various scenarios, fostering a new era of healthcare efficiency. Ultimately, this innovation has the potential to reshape the landscape of wound care, making the integration of technology and clinical practice more seamless than ever before.